Utah Medical Products Inc...

NASDAQ: UTMD · Real-Time Price · USD
55.93
-0.94 (-1.65%)
At close: Aug 15, 2025, 12:28 PM

Utah Medical Products Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
13.87M 16.64M 16.47M 14.79M
Depreciation & Amortization
2.85M 6.37M 7.08M 7.28M
Stock-Based Compensation
256K 225K 183K 166K
Other Working Capital
-1.54M -1.38M 174K 590K
Other Non-Cash Items
-415K -33K 36K 63K
Deferred Income Tax
n/a -681K -401K -92K
Change in Working Capital
-1.8M -233K -2.23M -1.01M
Operating Cash Flow
14.83M 22.28M 21.15M 21.2M
Capital Expenditures
-235K -639K -818K -552K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
27K n/a -9K n/a
Investing Cash Flow
-208K -639K -818K -552K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
-19.97M -2.5M -2.5M -6.98M
Dividend Paid
-4.26M -4.28M -3.16M -11.46M
Other Financial Acitivies
n/a 117K 174K 560K
Financial Cash Flow
-23.84M -4.17M -5.48M -10.9M
Net Cash Flow
-9.89M 17.82M 14.08M 9.38M
Free Cash Flow
14.6M 21.64M 20.33M 20.65M